Search Result "vascular endothelialgrowth factor receptor 2 (VEGFR2)."
Single Nucleotide Polymorphism and Serum Levels of VEGFR2 are Associated With Age Related Macular Degeneration
Journal: Current Neurovascular Research
Volume: 9 Issue: 4 Year: 2012 Page: 256-265
Author(s): Neel Kamal Sharma,Amod Gupta,Sudesh Prabhakar,Ramandeep Singh,Suresh Sharma,Akshay Anand
The Lymphangiogenic Factor CCBE1 Promotes Angiogenesis andTumor Growth in Colorectal Cancer
Journal: Current Molecular Medicine
Volume: 22 Issue: 9 Year: 2022 Page: 819-825
Author(s): Jiajun Zhi,Wenfang Tang,Wenjun Ding
Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactionsfor Cancer Therapeutics
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 10 Year: 2022 Page: 2026-2035
Author(s): Samaneh Ghasemali,Safar Farajnia,Abolfazl Barzegar,Babak Negahdari,Leila Rahbarnia
Utilization of Apatinib-Loaded Nanoparticles for the Treatment of Ocular Neovascularization
Journal: Current Drug Delivery
Volume: 16 Issue: 2 Year: 2019 Page: 153-163
Author(s): Kathleen Halasz,Shannon J. Kelly,Muhammad Tajwar Iqbal,Yashwant Pathak,Vijaykumar Sutariya
Coagulation Factor XIIIA (F13A1): Novel Perspectives in Treatment and Pharmacogenetics
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 11 Year: 2016 Page: 1449-1459
Author(s): Donato Gemmati,Marco Vigliano,Francesco Burini,Rosella Mari,Hodeib Hossam Abd El Mohsein,Francesco Parmeggiani,Maria L. Serino
Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review
Journal: Current Drug Targets
Volume: 18 Issue: 10 Year: 2017 Page: 1204-1213
Author(s): Simone A.M. Badal,William D. Aiken,Sheray N. Chin
Computational Studies on Isolated Compounds of Sclerochloa dura; their Efficacy towards Carbonic Anhydrase Inhibition and Anti-cancer Drug Targets
Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 12 Year: 2021 Page: 1107-1116
Author(s): Majid Ali,Asma Zaidi,Umar Farooq,Rizwana Sarwar,Syed Majid Bukhari
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies
Journal: Current Vascular Pharmacology
Volume: 10 Issue: 4 Year: 2012 Page: 479-493
Author(s): Patrizia Ferroni,David Della-Morte,Raffaele Palmirotta,Tatjana Rundek,Fiorella Guadagni,Mario Roselli
A Curcumin Analog, GO-Y078, Effectively Inhibits Angiogenesis through Actin Disorganization
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16 Issue: 5 Year: 2016 Page: 633-647
Author(s): Shunsuke Sugiyama,Yuki Yoshino,Sei Kuriyama,Masahiro Inoue,Keigo Komine,Kazunori Otsuka,Aki Kohyama,Hiroyuki Yamakoshi,Chikashi Ishioka,Masamitsu Tanaka,Yoshiharu Iwabuchi,Hiroyuki Shibata
Is there a Role for Bevacizumab in Non-Glial Tumors?
Journal: Current Drug Targets
Volume: 16 Issue: 7 Year: 2015 Page: 684-688
Author(s): Elisa Trevisan,Luca Bertero,Michela Magistrello,Roberta Ruda,Riccardo Soffietti